| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $295,700 ) |
| | 2024 | 2024 | PARION SCIENCES, INC | 2800 MERIDIAN PKWY STE 195 | DURHAM | NC | 27713-5257 | DURHAM | USA | R44HL174235 | A Novel ENaC Blocker/Osmolyte Inhalation Solution for the Treatment of Muco-Obstructive Lung Diseases | 000 | 1 | NIH | 4/26/2024 | $295,700 |
|
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2020 | PARION SCIENCES, INC. | 2800 MERIDIAN PKWY STE 195 | DURHAM | NC | 27713-5257 | DURHAM | USA | R43AI145766 | Novel Dual Acting Antibiotics for Pulmonary Disease | 000 | 1 | NIH | 11/10/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2020 | PARION SCIENCES, INC. | 2800 MERIDIAN PKWY STE 195 | DURHAM | NC | 27713-5257 | DURHAM | USA | R43AI145766 | Novel Dual Acting Antibiotics for Pulmonary Disease | 000 | 1 | NIH | 3/29/2021 | $0 |
| | 2021 | 2020 | PARION SCIENCES, INC. | 2800 MERIDIAN PKWY STE 195 | DURHAM | NC | 27713-5257 | DURHAM | USA | R43AI145766 | Novel Dual Acting Antibiotics for Pulmonary Disease | 001 | 1 | NIH | 7/23/2021 | $0 |
| | 2021 | 2020 | PARION SCIENCES, INC. | 2800 MERIDIAN PKWY STE 195 | DURHAM | NC | 27713-5257 | DURHAM | USA | R43AI145766 | Novel Dual Acting Antibiotics for Pulmonary Disease | 002 | 1 | NIH | 9/3/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $274,173 ) |
| | 2020 | 2020 | PARION SCIENCES, INC. | 2800 MERIDIAN PKWY STE 195 | DURHAM | NC | 27713-5257 | DURHAM | USA | R43AI145766 | Novel Dual Acting Antibiotics for Pulmonary Disease | 000 | 1 | NIH | 1/27/2020 | $274,173 |
|
| Issue Date FY: 2013 ( Subtotal = $1,828,432 ) |
| | 2013 | 2013 | PARION SCIENCES | 2525 MERIDIAN PARKWAY | DURHAM | NC | 27713-5243 | DURHAM | USA | R43HL112436 | NOVEL MUCOLYTIC AGENTS | 000 | 1 | NIH | 9/5/2013 | $319,012 |
| | 2013 | 2013 | PARION SCIENCES | 2525 MERIDIAN PARKWAY | DURHAM | NC | 27713-5243 | DURHAM | USA | R44HL110502 | HYPERTONIC SALINE FOR CYSTIC FIBROSIS | 000 | 2 | NIH | 8/19/2013 | $1,509,420 |
|
| Issue Date FY: 2011 ( Subtotal = $1,304,523 ) |
| | 2011 | 2011 | PARION SCIENCES | 2525 MERIDIAN PARKWAY | DURHAM | NC | 27713-5243 | DURHAM | USA | R44EY020705 | THE DEVELOPMENT EPITHELIAL SODIUM CHANNEL BLOCKERS FOR CHRONIC DRY EYE | 000 | 2 | NIH | 7/18/2011 | $1,059,726 |
| | 2011 | 2011 | PARION SCIENCES | 2525 MERIDIAN PARKWAY | DURHAM | NC | 27713-5243 | DURHAM | USA | R43HL110502 | HYPERTONIC SALINE FOR CYSTIC FIBROSIS | 000 | 1 | NIH | 8/23/2011 | $244,797 |
| | 2011 | 2010 | PARION SCIENCES | 2525 MERIDIAN PARKWAY | DURHAM | NC | 27713 | DURHAM | USA | R43EY020705 | THE DEVELOPMENT EPITHELIAL SODIUM CHANNEL BLOCKERS FOR CHRONIC DRY EYE | 000 | 1 | NIH | 7/18/2011 | $0 |
| | 2011 | 2010 | PARION SCIENCES | 2525 MERIDIAN PARKWAY | DURHAM | NC | 27713 | DURHAM | USA | RC1AI081297 | NOVEL THERAPIES FOR ENHANCING CLEARANCE OF INHALED RADIOACTIVE PARTICLES | 001 | 1 | NIH | 1/13/2011 | $0 |
| | 2011 | 2008 | PARION SCIENCES | 2525 MERIDIAN PARKWAY | DURHAM | NC | 27713 | DURHAM | USA | RC1AI081297 | NOVEL THERAPIES FOR ENHANCING CLEARANCE OF INHALED RADIOACTIVE PARTICLES | 000 | 1 | NIH | 1/13/2011 | $0 |
|
| Issue Date FY: 2010 ( Subtotal = $499,273 ) |
| | 2010 | 2010 | PARION SCIENCES | 2525 MERIDIAN PARKWAY | DURHAM | NC | 27713-5243 | DURHAM | USA | RC1AI081297 | NOVEL THERAPIES FOR ENHANCING CLEARANCE OF INHALED RADIOACTIVE PARTICLES | 000 | 1 | NIH | 4/1/2010 | $340,009 |
| | 2010 | 2010 | PARION SCIENCES | 2525 MERIDIAN PARKWAY | DURHAM | NC | 27713-5243 | DURHAM | USA | R43EY020705 | THE DEVELOPMENT EPITHELIAL SODIUM CHANNEL BLOCKERS FOR CHRONIC DRY EYE | 000 | 1 | NIH | 4/20/2010 | $159,264 |
| | 2010 | 2009 | PARION SCIENCES | 2525 MERIDIAN PARKWAY | DURHAM | NC | 27713 | DURHAM | USA | R44DE020042 | PHARMACOTHERAPRY FOR XEROSTOMIA IN SJOGREN'S SYNDROME | 000 | 2 | NIH | 10/23/2009 | $0 |
|
| Issue Date FY: 2009 ( Subtotal = $879,296 ) |
| | 2009 | 2009 | PARION SCIENCES | 2525 MERIDIAN PARKWAY | DURHAM | NC | 27713-5243 | DURHAM | USA | RC1AI081297 | NOVEL THERAPIES FOR ENHANCING CLEARANCE OF INHALED RADIOACTIVE PARTICLES | 001 | 1 | NIH | 9/15/2009 | $500,000 |
| | 2009 | 2009 | PARION SCIENCES | 2525 MERIDIAN PARKWAY | DURHAM | NC | 27713-5243 | DURHAM | USA | R44DE020042 | PHARMACOTHERAPRY FOR XEROSTOMIA IN SJOGREN'S SYNDROME | 000 | 2 | NIH | 8/14/2009 | $379,296 |
| | 2009 | 2009 | PARION SCIENCES | 2525 MERIDIAN PARKWAY | DURHAM | NC | 27713 | DURHAM | USA | R44DE020042 | PHARMACOTHERAPRY FOR XEROSTOMIA IN SJOGREN'S SYNDROME | 001 | 2 | NIH | 10/21/2009 | $0 |
| | 2009 | 2008 | PARION SCIENCES | 2525 MERIDIAN PARKWAY | DURHAM | NC | 27713 | DURHAM | USA | RC1AI081297 | NOVEL THERAPIES FOR ENHANCING CLEARANCE OF INHALED RADIOACTIVE PARTICLES | 000 | 1 | NIH | 7/23/2009 | $0 |
|
| Issue Date FY: 2008 ( Subtotal = $850,311 ) |
| | 2008 | 2008 | PARION SCIENCES | 2525 MERIDIAN PARKWAY | DURHAM | NC | 27713 | DURHAM | USA | RC1AI081297 | NOVEL THERAPIES FOR ENHANCING CLEARANCE OF INHALED RADIOACTIVE PARTICLES | 000 | 1 | NIH | 9/15/2008 | $850,311 |
|
| Issue Date FY: 2006 ( Subtotal = $983,544 ) |
| | 2006 | 2006 | PARION SCIENCES | 2525 MERIDIAN PARKWAY | DURHAM | NC | 27713 | DURHAM | USA | R44HL082340 | DEVELOPMENT OF EPITHELIAL SODIUM CHANNEL BLOCKERS FOR CF | 000 | 2 | NIH | 9/4/2006 | $983,544 |
|
| Issue Date FY: 2005 ( Subtotal = $854,500 ) |
| | 2005 | 2005 | PARION SCIENCES | 2525 MERIDIAN PARKWAY | DURHAM | NC | 27713 | DURHAM | USA | R44HL082340 | DEVELOPMENT OF EPITHELIAL SODIUM CHANNEL BLOCKERS FOR CF | 000 | 1 | NIH | 9/19/2005 | $364,501 |
| | 2005 | 2005 | PARION SCIENCES | 2525 MERIDIAN PARKWAY | DURHAM | NC | 27713 | DURHAM | USA | R43AR052986 | PHARMACOTHERAPY FOR XEROSTOMIA IN SJOGREN'S SYNDROME | 000 | 1 | NIH | 9/22/2005 | $2,000 |
| | 2005 | 2005 | PARION SCIENCES | 2525 MERIDIAN PARKWAY | DURHAM | NC | 27713 | DURHAM | USA | R43AR052986 | PHARMACOTHERAPY FOR XEROSTOMIA IN SJOGREN'S SYNDROME | 000 | 1 | NIH | 9/22/2005 | $487,999 |
|
|
